nodes	percent_of_prediction	percent_of_DWPC	metapath
Zalcitabine—CYP3A7—Sorafenib—liver cancer	0.111	0.224	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Sorafenib—liver cancer	0.111	0.224	CbGbCtD
Zalcitabine—CYP3A5—Sorafenib—liver cancer	0.0832	0.168	CbGbCtD
Zalcitabine—CYP2C9—Sorafenib—liver cancer	0.0558	0.113	CbGbCtD
Zalcitabine—CYP2D6—Sorafenib—liver cancer	0.051	0.103	CbGbCtD
Zalcitabine—CYP3A4—Sorafenib—liver cancer	0.0325	0.0656	CbGbCtD
Zalcitabine—CYP2D6—Doxorubicin—liver cancer	0.031	0.0626	CbGbCtD
Zalcitabine—CYP3A4—Doxorubicin—liver cancer	0.0197	0.0398	CbGbCtD
Zalcitabine—DCK—Doxorubicin—Epirubicin—liver cancer	0.00321	0.519	CbGdCrCtD
Zalcitabine—DCK—Epirubicin—Doxorubicin—liver cancer	0.00297	0.481	CbGdCrCtD
Zalcitabine—Candida infection—Doxorubicin—liver cancer	0.000661	0.00188	CcSEcCtD
Zalcitabine—Skin exfoliation—Doxorubicin—liver cancer	0.000661	0.00188	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000658	0.00187	CcSEcCtD
Zalcitabine—Hypertonia—Epirubicin—liver cancer	0.000656	0.00187	CcSEcCtD
Zalcitabine—Vaginal infection—Doxorubicin—liver cancer	0.000654	0.00186	CcSEcCtD
Zalcitabine—Blood urea increased—Doxorubicin—liver cancer	0.000654	0.00186	CcSEcCtD
Zalcitabine—Abnormal vision—Epirubicin—liver cancer	0.000653	0.00186	CcSEcCtD
Zalcitabine—Mental disability—Epirubicin—liver cancer	0.00065	0.00185	CcSEcCtD
Zalcitabine—Dyspnoea—Sorafenib—liver cancer	0.000644	0.00183	CcSEcCtD
Zalcitabine—Dry eye—Doxorubicin—liver cancer	0.00064	0.00182	CcSEcCtD
Zalcitabine—Lymphadenopathy—Epirubicin—liver cancer	0.000637	0.00181	CcSEcCtD
Zalcitabine—Cramps of lower extremities—Doxorubicin—liver cancer	0.000636	0.00181	CcSEcCtD
Zalcitabine—Dyspepsia—Sorafenib—liver cancer	0.000636	0.00181	CcSEcCtD
Zalcitabine—Oesophagitis—Doxorubicin—liver cancer	0.000633	0.0018	CcSEcCtD
Zalcitabine—Rash maculo-papular—Doxorubicin—liver cancer	0.000629	0.00179	CcSEcCtD
Zalcitabine—Decreased appetite—Sorafenib—liver cancer	0.000628	0.00179	CcSEcCtD
Zalcitabine—Bladder pain—Doxorubicin—liver cancer	0.000626	0.00178	CcSEcCtD
Zalcitabine—Blood alkaline phosphatase increased—Epirubicin—liver cancer	0.000625	0.00178	CcSEcCtD
Zalcitabine—Diabetes mellitus—Epirubicin—liver cancer	0.000625	0.00178	CcSEcCtD
Zalcitabine—Fatigue—Sorafenib—liver cancer	0.000623	0.00177	CcSEcCtD
Zalcitabine—Pain—Sorafenib—liver cancer	0.000618	0.00176	CcSEcCtD
Zalcitabine—Vascular purpura—Epirubicin—liver cancer	0.000607	0.00173	CcSEcCtD
Zalcitabine—Hypertonia—Doxorubicin—liver cancer	0.000607	0.00173	CcSEcCtD
Zalcitabine—Abnormal vision—Doxorubicin—liver cancer	0.000604	0.00172	CcSEcCtD
Zalcitabine—Eye pain—Epirubicin—liver cancer	0.000602	0.00171	CcSEcCtD
Zalcitabine—Mental disability—Doxorubicin—liver cancer	0.000601	0.00171	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Sorafenib—liver cancer	0.000591	0.00168	CcSEcCtD
Zalcitabine—Lymphadenopathy—Doxorubicin—liver cancer	0.000589	0.00168	CcSEcCtD
Zalcitabine—Renal failure acute—Epirubicin—liver cancer	0.000589	0.00168	CcSEcCtD
Zalcitabine—Hot flush—Epirubicin—liver cancer	0.000581	0.00165	CcSEcCtD
Zalcitabine—Diabetes mellitus—Doxorubicin—liver cancer	0.000578	0.00165	CcSEcCtD
Zalcitabine—Blood alkaline phosphatase increased—Doxorubicin—liver cancer	0.000578	0.00165	CcSEcCtD
Zalcitabine—Dermatitis exfoliative—Epirubicin—liver cancer	0.000576	0.00164	CcSEcCtD
Zalcitabine—Menopausal symptoms—Epirubicin—liver cancer	0.000576	0.00164	CcSEcCtD
Zalcitabine—Urticaria—Sorafenib—liver cancer	0.000574	0.00163	CcSEcCtD
Zalcitabine—Abdominal pain—Sorafenib—liver cancer	0.000571	0.00163	CcSEcCtD
Zalcitabine—Body temperature increased—Sorafenib—liver cancer	0.000571	0.00163	CcSEcCtD
Zalcitabine—Renal impairment—Epirubicin—liver cancer	0.000571	0.00163	CcSEcCtD
Zalcitabine—Dermatitis bullous—Epirubicin—liver cancer	0.000568	0.00162	CcSEcCtD
Zalcitabine—Purpura—Epirubicin—liver cancer	0.000564	0.00161	CcSEcCtD
Zalcitabine—Vascular purpura—Doxorubicin—liver cancer	0.000562	0.0016	CcSEcCtD
Zalcitabine—Eye pain—Doxorubicin—liver cancer	0.000557	0.00159	CcSEcCtD
Zalcitabine—Cardiac failure—Epirubicin—liver cancer	0.000557	0.00159	CcSEcCtD
Zalcitabine—Hypoglycaemia—Epirubicin—liver cancer	0.000557	0.00159	CcSEcCtD
Zalcitabine—Hyponatraemia—Epirubicin—liver cancer	0.000546	0.00155	CcSEcCtD
Zalcitabine—Renal failure acute—Doxorubicin—liver cancer	0.000545	0.00155	CcSEcCtD
Zalcitabine—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.000543	0.00155	CcSEcCtD
Zalcitabine—Osteoarthritis—Epirubicin—liver cancer	0.000543	0.00155	CcSEcCtD
Zalcitabine—Pain in extremity—Epirubicin—liver cancer	0.000543	0.00155	CcSEcCtD
Zalcitabine—Hot flush—Doxorubicin—liver cancer	0.000537	0.00153	CcSEcCtD
Zalcitabine—Affect lability—Epirubicin—liver cancer	0.000535	0.00152	CcSEcCtD
Zalcitabine—Migraine—Epirubicin—liver cancer	0.000535	0.00152	CcSEcCtD
Zalcitabine—Menopausal symptoms—Doxorubicin—liver cancer	0.000533	0.00152	CcSEcCtD
Zalcitabine—Dermatitis exfoliative—Doxorubicin—liver cancer	0.000533	0.00152	CcSEcCtD
Zalcitabine—Hypersensitivity—Sorafenib—liver cancer	0.000532	0.00152	CcSEcCtD
Zalcitabine—Renal impairment—Doxorubicin—liver cancer	0.000528	0.0015	CcSEcCtD
Zalcitabine—Dermatitis bullous—Doxorubicin—liver cancer	0.000526	0.0015	CcSEcCtD
Zalcitabine—Purpura—Doxorubicin—liver cancer	0.000522	0.00149	CcSEcCtD
Zalcitabine—Asthenia—Sorafenib—liver cancer	0.000518	0.00148	CcSEcCtD
Zalcitabine—Hypoglycaemia—Doxorubicin—liver cancer	0.000515	0.00147	CcSEcCtD
Zalcitabine—Cardiac failure—Doxorubicin—liver cancer	0.000515	0.00147	CcSEcCtD
Zalcitabine—Mood swings—Epirubicin—liver cancer	0.000515	0.00147	CcSEcCtD
Zalcitabine—Pruritus—Sorafenib—liver cancer	0.000511	0.00146	CcSEcCtD
Zalcitabine—Ataxia—Epirubicin—liver cancer	0.000511	0.00145	CcSEcCtD
Zalcitabine—Blood creatinine increased—Epirubicin—liver cancer	0.000509	0.00145	CcSEcCtD
Zalcitabine—Hyponatraemia—Doxorubicin—liver cancer	0.000505	0.00144	CcSEcCtD
Zalcitabine—Pain in extremity—Doxorubicin—liver cancer	0.000503	0.00143	CcSEcCtD
Zalcitabine—Osteoarthritis—Doxorubicin—liver cancer	0.000503	0.00143	CcSEcCtD
Zalcitabine—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.000503	0.00143	CcSEcCtD
Zalcitabine—Dry skin—Epirubicin—liver cancer	0.000498	0.00142	CcSEcCtD
Zalcitabine—Abdominal pain upper—Epirubicin—liver cancer	0.000496	0.00141	CcSEcCtD
Zalcitabine—Affect lability—Doxorubicin—liver cancer	0.000495	0.00141	CcSEcCtD
Zalcitabine—Migraine—Doxorubicin—liver cancer	0.000495	0.00141	CcSEcCtD
Zalcitabine—Hypokalaemia—Epirubicin—liver cancer	0.000494	0.00141	CcSEcCtD
Zalcitabine—Diarrhoea—Sorafenib—liver cancer	0.000494	0.00141	CcSEcCtD
Zalcitabine—Nasopharyngitis—Epirubicin—liver cancer	0.000486	0.00138	CcSEcCtD
Zalcitabine—Gastritis—Epirubicin—liver cancer	0.000481	0.00137	CcSEcCtD
Zalcitabine—Muscular weakness—Epirubicin—liver cancer	0.000479	0.00136	CcSEcCtD
Zalcitabine—Dizziness—Sorafenib—liver cancer	0.000478	0.00136	CcSEcCtD
Zalcitabine—Mood swings—Doxorubicin—liver cancer	0.000476	0.00136	CcSEcCtD
Zalcitabine—Abdominal distension—Epirubicin—liver cancer	0.000473	0.00135	CcSEcCtD
Zalcitabine—Ataxia—Doxorubicin—liver cancer	0.000473	0.00135	CcSEcCtD
Zalcitabine—Blood creatinine increased—Doxorubicin—liver cancer	0.000471	0.00134	CcSEcCtD
Zalcitabine—Dysphagia—Epirubicin—liver cancer	0.00047	0.00134	CcSEcCtD
Zalcitabine—Eosinophilia—Epirubicin—liver cancer	0.000465	0.00132	CcSEcCtD
Zalcitabine—Dry skin—Doxorubicin—liver cancer	0.000461	0.00131	CcSEcCtD
Zalcitabine—Pancreatitis—Epirubicin—liver cancer	0.00046	0.00131	CcSEcCtD
Zalcitabine—Vomiting—Sorafenib—liver cancer	0.000459	0.00131	CcSEcCtD
Zalcitabine—Abdominal pain upper—Doxorubicin—liver cancer	0.000459	0.00131	CcSEcCtD
Zalcitabine—Hypokalaemia—Doxorubicin—liver cancer	0.000458	0.0013	CcSEcCtD
Zalcitabine—Rash—Sorafenib—liver cancer	0.000456	0.0013	CcSEcCtD
Zalcitabine—Dermatitis—Sorafenib—liver cancer	0.000455	0.0013	CcSEcCtD
Zalcitabine—Headache—Sorafenib—liver cancer	0.000453	0.00129	CcSEcCtD
Zalcitabine—Nasopharyngitis—Doxorubicin—liver cancer	0.00045	0.00128	CcSEcCtD
Zalcitabine—Gastritis—Doxorubicin—liver cancer	0.000445	0.00127	CcSEcCtD
Zalcitabine—Muscular weakness—Doxorubicin—liver cancer	0.000443	0.00126	CcSEcCtD
Zalcitabine—Neutropenia—Epirubicin—liver cancer	0.000439	0.00125	CcSEcCtD
Zalcitabine—Dysuria—Epirubicin—liver cancer	0.000439	0.00125	CcSEcCtD
Zalcitabine—Abdominal distension—Doxorubicin—liver cancer	0.000437	0.00125	CcSEcCtD
Zalcitabine—Dysphagia—Doxorubicin—liver cancer	0.000435	0.00124	CcSEcCtD
Zalcitabine—Pollakiuria—Epirubicin—liver cancer	0.000434	0.00124	CcSEcCtD
Zalcitabine—Eosinophilia—Doxorubicin—liver cancer	0.00043	0.00122	CcSEcCtD
Zalcitabine—Photosensitivity reaction—Epirubicin—liver cancer	0.000429	0.00122	CcSEcCtD
Zalcitabine—Pancreatitis—Doxorubicin—liver cancer	0.000426	0.00121	CcSEcCtD
Zalcitabine—Weight decreased—Epirubicin—liver cancer	0.000425	0.00121	CcSEcCtD
Zalcitabine—Hyperglycaemia—Epirubicin—liver cancer	0.000424	0.00121	CcSEcCtD
Zalcitabine—Neuropathy peripheral—Epirubicin—liver cancer	0.00041	0.00117	CcSEcCtD
Zalcitabine—Jaundice—Epirubicin—liver cancer	0.000408	0.00116	CcSEcCtD
Zalcitabine—Dysuria—Doxorubicin—liver cancer	0.000406	0.00116	CcSEcCtD
Zalcitabine—Neutropenia—Doxorubicin—liver cancer	0.000406	0.00116	CcSEcCtD
Zalcitabine—Pollakiuria—Doxorubicin—liver cancer	0.000401	0.00114	CcSEcCtD
Zalcitabine—Photosensitivity reaction—Doxorubicin—liver cancer	0.000397	0.00113	CcSEcCtD
Zalcitabine—Epistaxis—Epirubicin—liver cancer	0.000395	0.00112	CcSEcCtD
Zalcitabine—Weight decreased—Doxorubicin—liver cancer	0.000393	0.00112	CcSEcCtD
Zalcitabine—Sinusitis—Epirubicin—liver cancer	0.000393	0.00112	CcSEcCtD
Zalcitabine—Hyperglycaemia—Doxorubicin—liver cancer	0.000392	0.00112	CcSEcCtD
Zalcitabine—Neuropathy peripheral—Doxorubicin—liver cancer	0.00038	0.00108	CcSEcCtD
Zalcitabine—Jaundice—Doxorubicin—liver cancer	0.000378	0.00108	CcSEcCtD
Zalcitabine—Rhinitis—Epirubicin—liver cancer	0.000377	0.00107	CcSEcCtD
Zalcitabine—Hepatitis—Epirubicin—liver cancer	0.000376	0.00107	CcSEcCtD
Zalcitabine—Pharyngitis—Epirubicin—liver cancer	0.000373	0.00106	CcSEcCtD
Zalcitabine—Epistaxis—Doxorubicin—liver cancer	0.000365	0.00104	CcSEcCtD
Zalcitabine—Sinusitis—Doxorubicin—liver cancer	0.000363	0.00103	CcSEcCtD
Zalcitabine—Visual impairment—Epirubicin—liver cancer	0.000362	0.00103	CcSEcCtD
Zalcitabine—Eye disorder—Epirubicin—liver cancer	0.000351	0.001	CcSEcCtD
Zalcitabine—Tinnitus—Epirubicin—liver cancer	0.00035	0.000998	CcSEcCtD
Zalcitabine—Flushing—Epirubicin—liver cancer	0.000349	0.000993	CcSEcCtD
Zalcitabine—Rhinitis—Doxorubicin—liver cancer	0.000349	0.000993	CcSEcCtD
Zalcitabine—Hepatitis—Doxorubicin—liver cancer	0.000348	0.00099	CcSEcCtD
Zalcitabine—Pharyngitis—Doxorubicin—liver cancer	0.000345	0.000983	CcSEcCtD
Zalcitabine—Chills—Epirubicin—liver cancer	0.000337	0.00096	CcSEcCtD
Zalcitabine—Arrhythmia—Epirubicin—liver cancer	0.000336	0.000956	CcSEcCtD
Zalcitabine—Visual impairment—Doxorubicin—liver cancer	0.000335	0.000954	CcSEcCtD
Zalcitabine—Alopecia—Epirubicin—liver cancer	0.000332	0.000946	CcSEcCtD
Zalcitabine—Eye disorder—Doxorubicin—liver cancer	0.000325	0.000925	CcSEcCtD
Zalcitabine—Tinnitus—Doxorubicin—liver cancer	0.000324	0.000923	CcSEcCtD
Zalcitabine—Flushing—Doxorubicin—liver cancer	0.000323	0.000919	CcSEcCtD
Zalcitabine—Flatulence—Epirubicin—liver cancer	0.000322	0.000918	CcSEcCtD
Zalcitabine—Tension—Epirubicin—liver cancer	0.000321	0.000914	CcSEcCtD
Zalcitabine—Dysgeusia—Epirubicin—liver cancer	0.00032	0.000912	CcSEcCtD
Zalcitabine—Nervousness—Epirubicin—liver cancer	0.000318	0.000905	CcSEcCtD
Zalcitabine—Back pain—Epirubicin—liver cancer	0.000317	0.000901	CcSEcCtD
Zalcitabine—Muscle spasms—Epirubicin—liver cancer	0.000315	0.000896	CcSEcCtD
Zalcitabine—Chills—Doxorubicin—liver cancer	0.000312	0.000889	CcSEcCtD
Zalcitabine—Arrhythmia—Doxorubicin—liver cancer	0.000311	0.000885	CcSEcCtD
Zalcitabine—Vision blurred—Epirubicin—liver cancer	0.000308	0.000878	CcSEcCtD
Zalcitabine—Alopecia—Doxorubicin—liver cancer	0.000307	0.000875	CcSEcCtD
Zalcitabine—Ill-defined disorder—Epirubicin—liver cancer	0.000304	0.000864	CcSEcCtD
Zalcitabine—Anaemia—Epirubicin—liver cancer	0.000302	0.000861	CcSEcCtD
Zalcitabine—Agitation—Epirubicin—liver cancer	0.000301	0.000856	CcSEcCtD
Zalcitabine—Flatulence—Doxorubicin—liver cancer	0.000298	0.000849	CcSEcCtD
Zalcitabine—Tension—Doxorubicin—liver cancer	0.000297	0.000846	CcSEcCtD
Zalcitabine—Dysgeusia—Doxorubicin—liver cancer	0.000296	0.000844	CcSEcCtD
Zalcitabine—Malaise—Epirubicin—liver cancer	0.000295	0.00084	CcSEcCtD
Zalcitabine—Nervousness—Doxorubicin—liver cancer	0.000294	0.000837	CcSEcCtD
Zalcitabine—Vertigo—Epirubicin—liver cancer	0.000294	0.000837	CcSEcCtD
Zalcitabine—Syncope—Epirubicin—liver cancer	0.000293	0.000836	CcSEcCtD
Zalcitabine—Leukopenia—Epirubicin—liver cancer	0.000293	0.000834	CcSEcCtD
Zalcitabine—Back pain—Doxorubicin—liver cancer	0.000293	0.000834	CcSEcCtD
Zalcitabine—Muscle spasms—Doxorubicin—liver cancer	0.000291	0.000829	CcSEcCtD
Zalcitabine—Palpitations—Epirubicin—liver cancer	0.000289	0.000823	CcSEcCtD
Zalcitabine—Loss of consciousness—Epirubicin—liver cancer	0.000288	0.000819	CcSEcCtD
Zalcitabine—Cough—Epirubicin—liver cancer	0.000286	0.000813	CcSEcCtD
Zalcitabine—Vision blurred—Doxorubicin—liver cancer	0.000285	0.000812	CcSEcCtD
Zalcitabine—Convulsion—Epirubicin—liver cancer	0.000283	0.000807	CcSEcCtD
Zalcitabine—Hypertension—Epirubicin—liver cancer	0.000282	0.000804	CcSEcCtD
Zalcitabine—Ill-defined disorder—Doxorubicin—liver cancer	0.000281	0.0008	CcSEcCtD
Zalcitabine—Anaemia—Doxorubicin—liver cancer	0.00028	0.000797	CcSEcCtD
Zalcitabine—Arthralgia—Epirubicin—liver cancer	0.000279	0.000793	CcSEcCtD
Zalcitabine—Myalgia—Epirubicin—liver cancer	0.000279	0.000793	CcSEcCtD
Zalcitabine—Agitation—Doxorubicin—liver cancer	0.000278	0.000792	CcSEcCtD
Zalcitabine—Anxiety—Epirubicin—liver cancer	0.000278	0.00079	CcSEcCtD
Zalcitabine—Discomfort—Epirubicin—liver cancer	0.000275	0.000784	CcSEcCtD
Zalcitabine—Malaise—Doxorubicin—liver cancer	0.000273	0.000777	CcSEcCtD
Zalcitabine—Dry mouth—Epirubicin—liver cancer	0.000272	0.000776	CcSEcCtD
Zalcitabine—Vertigo—Doxorubicin—liver cancer	0.000272	0.000775	CcSEcCtD
Zalcitabine—Syncope—Doxorubicin—liver cancer	0.000272	0.000773	CcSEcCtD
Zalcitabine—Leukopenia—Doxorubicin—liver cancer	0.000271	0.000772	CcSEcCtD
Zalcitabine—Confusional state—Epirubicin—liver cancer	0.000269	0.000767	CcSEcCtD
Zalcitabine—Palpitations—Doxorubicin—liver cancer	0.000268	0.000762	CcSEcCtD
Zalcitabine—Oedema—Epirubicin—liver cancer	0.000267	0.00076	CcSEcCtD
Zalcitabine—Loss of consciousness—Doxorubicin—liver cancer	0.000266	0.000758	CcSEcCtD
Zalcitabine—Infection—Epirubicin—liver cancer	0.000265	0.000755	CcSEcCtD
Zalcitabine—Cough—Doxorubicin—liver cancer	0.000264	0.000752	CcSEcCtD
Zalcitabine—Shock—Epirubicin—liver cancer	0.000263	0.000748	CcSEcCtD
Zalcitabine—Convulsion—Doxorubicin—liver cancer	0.000262	0.000747	CcSEcCtD
Zalcitabine—Thrombocytopenia—Epirubicin—liver cancer	0.000261	0.000744	CcSEcCtD
Zalcitabine—Hypertension—Doxorubicin—liver cancer	0.000261	0.000744	CcSEcCtD
Zalcitabine—Tachycardia—Epirubicin—liver cancer	0.000261	0.000742	CcSEcCtD
Zalcitabine—Skin disorder—Epirubicin—liver cancer	0.000259	0.000739	CcSEcCtD
Zalcitabine—Hyperhidrosis—Epirubicin—liver cancer	0.000258	0.000735	CcSEcCtD
Zalcitabine—Arthralgia—Doxorubicin—liver cancer	0.000258	0.000734	CcSEcCtD
Zalcitabine—Myalgia—Doxorubicin—liver cancer	0.000258	0.000734	CcSEcCtD
Zalcitabine—Anxiety—Doxorubicin—liver cancer	0.000257	0.000731	CcSEcCtD
Zalcitabine—Discomfort—Doxorubicin—liver cancer	0.000255	0.000725	CcSEcCtD
Zalcitabine—Anorexia—Epirubicin—liver cancer	0.000255	0.000725	CcSEcCtD
Zalcitabine—Dry mouth—Doxorubicin—liver cancer	0.000252	0.000718	CcSEcCtD
Zalcitabine—Confusional state—Doxorubicin—liver cancer	0.000249	0.000709	CcSEcCtD
Zalcitabine—Oedema—Doxorubicin—liver cancer	0.000247	0.000704	CcSEcCtD
Zalcitabine—Infection—Doxorubicin—liver cancer	0.000245	0.000699	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000243	0.000693	CcSEcCtD
Zalcitabine—Shock—Doxorubicin—liver cancer	0.000243	0.000692	CcSEcCtD
Zalcitabine—Thrombocytopenia—Doxorubicin—liver cancer	0.000242	0.000689	CcSEcCtD
Zalcitabine—Insomnia—Epirubicin—liver cancer	0.000242	0.000688	CcSEcCtD
Zalcitabine—Tachycardia—Doxorubicin—liver cancer	0.000241	0.000687	CcSEcCtD
Zalcitabine—Skin disorder—Doxorubicin—liver cancer	0.00024	0.000683	CcSEcCtD
Zalcitabine—Hyperhidrosis—Doxorubicin—liver cancer	0.000239	0.00068	CcSEcCtD
Zalcitabine—Dyspnoea—Epirubicin—liver cancer	0.000238	0.000678	CcSEcCtD
Zalcitabine—Somnolence—Epirubicin—liver cancer	0.000237	0.000676	CcSEcCtD
Zalcitabine—Anorexia—Doxorubicin—liver cancer	0.000236	0.000671	CcSEcCtD
Zalcitabine—Dyspepsia—Epirubicin—liver cancer	0.000235	0.000669	CcSEcCtD
Zalcitabine—Decreased appetite—Epirubicin—liver cancer	0.000232	0.000661	CcSEcCtD
Zalcitabine—Fatigue—Epirubicin—liver cancer	0.00023	0.000656	CcSEcCtD
Zalcitabine—Pain—Epirubicin—liver cancer	0.000228	0.00065	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000225	0.000641	CcSEcCtD
Zalcitabine—Insomnia—Doxorubicin—liver cancer	0.000223	0.000636	CcSEcCtD
Zalcitabine—Dyspnoea—Doxorubicin—liver cancer	0.00022	0.000627	CcSEcCtD
Zalcitabine—Feeling abnormal—Epirubicin—liver cancer	0.00022	0.000627	CcSEcCtD
Zalcitabine—Somnolence—Doxorubicin—liver cancer	0.00022	0.000625	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Epirubicin—liver cancer	0.000218	0.000622	CcSEcCtD
Zalcitabine—Dyspepsia—Doxorubicin—liver cancer	0.000218	0.000619	CcSEcCtD
Zalcitabine—Decreased appetite—Doxorubicin—liver cancer	0.000215	0.000612	CcSEcCtD
Zalcitabine—Fatigue—Doxorubicin—liver cancer	0.000213	0.000607	CcSEcCtD
Zalcitabine—Urticaria—Epirubicin—liver cancer	0.000212	0.000604	CcSEcCtD
Zalcitabine—Pain—Doxorubicin—liver cancer	0.000211	0.000602	CcSEcCtD
Zalcitabine—Abdominal pain—Epirubicin—liver cancer	0.000211	0.000601	CcSEcCtD
Zalcitabine—Body temperature increased—Epirubicin—liver cancer	0.000211	0.000601	CcSEcCtD
Zalcitabine—Feeling abnormal—Doxorubicin—liver cancer	0.000204	0.00058	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Doxorubicin—liver cancer	0.000202	0.000575	CcSEcCtD
Zalcitabine—Hypersensitivity—Epirubicin—liver cancer	0.000197	0.00056	CcSEcCtD
Zalcitabine—Urticaria—Doxorubicin—liver cancer	0.000196	0.000559	CcSEcCtD
Zalcitabine—Abdominal pain—Doxorubicin—liver cancer	0.000195	0.000556	CcSEcCtD
Zalcitabine—Body temperature increased—Doxorubicin—liver cancer	0.000195	0.000556	CcSEcCtD
Zalcitabine—Asthenia—Epirubicin—liver cancer	0.000192	0.000546	CcSEcCtD
Zalcitabine—Pruritus—Epirubicin—liver cancer	0.000189	0.000538	CcSEcCtD
Zalcitabine—Diarrhoea—Epirubicin—liver cancer	0.000183	0.00052	CcSEcCtD
Zalcitabine—Hypersensitivity—Doxorubicin—liver cancer	0.000182	0.000518	CcSEcCtD
Zalcitabine—Asthenia—Doxorubicin—liver cancer	0.000177	0.000505	CcSEcCtD
Zalcitabine—Dizziness—Epirubicin—liver cancer	0.000177	0.000503	CcSEcCtD
Zalcitabine—Pruritus—Doxorubicin—liver cancer	0.000175	0.000498	CcSEcCtD
Zalcitabine—Vomiting—Epirubicin—liver cancer	0.00017	0.000483	CcSEcCtD
Zalcitabine—Diarrhoea—Doxorubicin—liver cancer	0.000169	0.000481	CcSEcCtD
Zalcitabine—Rash—Epirubicin—liver cancer	0.000168	0.000479	CcSEcCtD
Zalcitabine—Dermatitis—Epirubicin—liver cancer	0.000168	0.000479	CcSEcCtD
Zalcitabine—Headache—Epirubicin—liver cancer	0.000167	0.000476	CcSEcCtD
Zalcitabine—Dizziness—Doxorubicin—liver cancer	0.000163	0.000465	CcSEcCtD
Zalcitabine—Vomiting—Doxorubicin—liver cancer	0.000157	0.000447	CcSEcCtD
Zalcitabine—Rash—Doxorubicin—liver cancer	0.000156	0.000444	CcSEcCtD
Zalcitabine—Dermatitis—Doxorubicin—liver cancer	0.000156	0.000443	CcSEcCtD
Zalcitabine—Headache—Doxorubicin—liver cancer	0.000155	0.000441	CcSEcCtD
Zalcitabine—CYP3A43—Metabolism—PSMD10—liver cancer	9.76e-05	0.000661	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—GOT2—liver cancer	9.64e-05	0.000653	CbGpPWpGaD
Zalcitabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	9.56e-05	0.000647	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—GOT2—liver cancer	9.5e-05	0.000643	CbGpPWpGaD
Zalcitabine—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	9.09e-05	0.000616	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—CYP2E1—liver cancer	9.07e-05	0.000614	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—CYP2E1—liver cancer	8.93e-05	0.000605	CbGpPWpGaD
Zalcitabine—CYP2D6—Biological oxidations—GSTP1—liver cancer	8.91e-05	0.000604	CbGpPWpGaD
Zalcitabine—SLC22A6—SLC-mediated transmembrane transport—ALB—liver cancer	8.84e-05	0.000599	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—GSTP1—liver cancer	8.84e-05	0.000599	CbGpPWpGaD
Zalcitabine—CYP2D6—Metapathway biotransformation—GSTP1—liver cancer	8.79e-05	0.000595	CbGpPWpGaD
Zalcitabine—CYP2C9—Metapathway biotransformation—GSTP1—liver cancer	8.72e-05	0.00059	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—HPGDS—liver cancer	8.67e-05	0.000587	CbGpPWpGaD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—PPARA—liver cancer	8.61e-05	0.000583	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—CYCS—liver cancer	8.6e-05	0.000583	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—CYCS—liver cancer	8.48e-05	0.000575	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—CYCS—liver cancer	8.35e-05	0.000566	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—GOT1—liver cancer	8.32e-05	0.000564	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—GGT1—liver cancer	8.32e-05	0.000564	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—GOT1—liver cancer	8.2e-05	0.000555	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—GGT1—liver cancer	8.2e-05	0.000555	CbGpPWpGaD
Zalcitabine—CYP2D6—Biological oxidations—GSTM1—liver cancer	8.19e-05	0.000555	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—UGDH—liver cancer	8.17e-05	0.000553	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—GSTM1—liver cancer	8.12e-05	0.00055	CbGpPWpGaD
Zalcitabine—CYP2D6—Metapathway biotransformation—GSTM1—liver cancer	8.08e-05	0.000547	CbGpPWpGaD
Zalcitabine—CYP2C9—Metapathway biotransformation—GSTM1—liver cancer	8.01e-05	0.000543	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	7.83e-05	0.000531	CbGpPWpGaD
Zalcitabine—CYP2D6—Biological oxidations—CYP1A1—liver cancer	7.77e-05	0.000526	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—CYP1A1—liver cancer	7.7e-05	0.000521	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—EPT1—liver cancer	7.68e-05	0.00052	CbGpPWpGaD
Zalcitabine—CYP2D6—Metapathway biotransformation—CYP1A1—liver cancer	7.66e-05	0.000519	CbGpPWpGaD
Zalcitabine—CYP2C9—Metapathway biotransformation—CYP1A1—liver cancer	7.59e-05	0.000514	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	7.55e-05	0.000512	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—HMOX1—liver cancer	7.48e-05	0.000507	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—GSTP1—liver cancer	7.48e-05	0.000506	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—HMOX1—liver cancer	7.37e-05	0.000499	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—GSTP1—liver cancer	7.36e-05	0.000499	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—TAT—liver cancer	7.28e-05	0.000493	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—HMOX1—liver cancer	7.26e-05	0.000492	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—CYP2E1—liver cancer	7.07e-05	0.000479	CbGpPWpGaD
Zalcitabine—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	6.97e-05	0.000472	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—GSTM1—liver cancer	6.87e-05	0.000465	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CPT1B—liver cancer	6.85e-05	0.000464	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GLUL—liver cancer	6.85e-05	0.000464	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—GSTM1—liver cancer	6.77e-05	0.000458	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—NR1H4—liver cancer	6.6e-05	0.000447	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—CYP1A1—liver cancer	6.51e-05	0.000441	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GSTA3—liver cancer	6.49e-05	0.00044	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—GGT1—liver cancer	6.49e-05	0.000439	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—CYP1A1—liver cancer	6.41e-05	0.000434	CbGpPWpGaD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—ALB—liver cancer	6.4e-05	0.000434	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—MTHFR—liver cancer	6.07e-05	0.000411	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—PPARA—liver cancer	6.04e-05	0.000409	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—MTHFR—liver cancer	5.98e-05	0.000405	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PPARA—liver cancer	5.96e-05	0.000404	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GSTA4—liver cancer	5.94e-05	0.000402	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PPARA—liver cancer	5.87e-05	0.000397	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—GSTP1—liver cancer	5.83e-05	0.000395	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—UGDH—liver cancer	5.81e-05	0.000393	CbGpPWpGaD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—RAF1—liver cancer	5.79e-05	0.000392	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GSTA2—liver cancer	5.78e-05	0.000392	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	5.77e-05	0.000391	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—UGDH—liver cancer	5.76e-05	0.00039	CbGpPWpGaD
Zalcitabine—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	5.75e-05	0.000389	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GSTA1—liver cancer	5.58e-05	0.000378	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—NAT2—liver cancer	5.52e-05	0.000374	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—EPT1—liver cancer	5.46e-05	0.00037	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—EPT1—liver cancer	5.41e-05	0.000367	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—GSTM1—liver cancer	5.36e-05	0.000363	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ALDOB—liver cancer	5.29e-05	0.000358	CbGpPWpGaD
Zalcitabine—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	5.28e-05	0.000358	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—TAT—liver cancer	5.18e-05	0.000351	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—TAT—liver cancer	5.13e-05	0.000348	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PIK3CG—liver cancer	5.1e-05	0.000346	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—CYP1A1—liver cancer	5.08e-05	0.000344	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	5.05e-05	0.000342	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CRABP1—liver cancer	5.05e-05	0.000342	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PIK3CG—liver cancer	5.02e-05	0.00034	CbGpPWpGaD
Zalcitabine—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	5.01e-05	0.000339	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GLUL—liver cancer	4.95e-05	0.000335	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CPT1B—liver cancer	4.95e-05	0.000335	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PPARG—liver cancer	4.92e-05	0.000334	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PPARG—liver cancer	4.85e-05	0.000328	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—NR1H4—liver cancer	4.77e-05	0.000323	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GSTA3—liver cancer	4.69e-05	0.000318	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—ALB—liver cancer	4.49e-05	0.000304	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PIK3CD—liver cancer	4.48e-05	0.000304	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—ALB—liver cancer	4.43e-05	0.0003	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PIK3CD—liver cancer	4.42e-05	0.000299	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—HPGDS—liver cancer	4.41e-05	0.000299	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—ALB—liver cancer	4.36e-05	0.000295	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GSTA4—liver cancer	4.29e-05	0.000291	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GSTA2—liver cancer	4.18e-05	0.000283	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—RAF1—liver cancer	4.06e-05	0.000275	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GSTA1—liver cancer	4.03e-05	0.000273	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—NAT2—liver cancer	3.99e-05	0.00027	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PSMA4—liver cancer	3.93e-05	0.000266	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PSMD10—liver cancer	3.93e-05	0.000266	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PIK3CB—liver cancer	3.91e-05	0.000265	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PIK3CB—liver cancer	3.85e-05	0.000261	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GOT2—liver cancer	3.82e-05	0.000259	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ALDOB—liver cancer	3.82e-05	0.000259	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—UGDH—liver cancer	3.8e-05	0.000257	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—liver cancer	3.78e-05	0.000256	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CRABP1—liver cancer	3.65e-05	0.000247	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CYP2E1—liver cancer	3.6e-05	0.000244	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—EPT1—liver cancer	3.57e-05	0.000242	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GLUL—liver cancer	3.52e-05	0.000238	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CPT1B—liver cancer	3.52e-05	0.000238	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CPT1B—liver cancer	3.49e-05	0.000236	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GLUL—liver cancer	3.49e-05	0.000236	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—NR1H4—liver cancer	3.39e-05	0.00023	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—TAT—liver cancer	3.38e-05	0.000229	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CYCS—liver cancer	3.36e-05	0.000228	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—NR1H4—liver cancer	3.36e-05	0.000228	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GSTA3—liver cancer	3.34e-05	0.000226	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GSTA3—liver cancer	3.31e-05	0.000224	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GGT1—liver cancer	3.3e-05	0.000224	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GOT1—liver cancer	3.3e-05	0.000224	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—HPGDS—liver cancer	3.19e-05	0.000216	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GSTA4—liver cancer	3.05e-05	0.000207	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GSTA4—liver cancer	3.02e-05	0.000205	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GSTA2—liver cancer	2.97e-05	0.000201	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GSTP1—liver cancer	2.97e-05	0.000201	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.96e-05	0.0002	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GSTA2—liver cancer	2.95e-05	0.0002	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—HMOX1—liver cancer	2.92e-05	0.000198	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GSTA1—liver cancer	2.87e-05	0.000194	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GSTA1—liver cancer	2.84e-05	0.000193	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PSMA4—liver cancer	2.84e-05	0.000193	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PSMD10—liver cancer	2.84e-05	0.000193	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—NAT2—liver cancer	2.84e-05	0.000192	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—NAT2—liver cancer	2.81e-05	0.00019	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GOT2—liver cancer	2.76e-05	0.000187	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GSTM1—liver cancer	2.73e-05	0.000185	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ALDOB—liver cancer	2.72e-05	0.000184	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.7e-05	0.000183	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ALDOB—liver cancer	2.7e-05	0.000183	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CYP2E1—liver cancer	2.6e-05	0.000176	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CRABP1—liver cancer	2.59e-05	0.000176	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CYP1A1—liver cancer	2.58e-05	0.000175	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CRABP1—liver cancer	2.57e-05	0.000174	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CYCS—liver cancer	2.43e-05	0.000165	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—MTHFR—liver cancer	2.41e-05	0.000163	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GOT1—liver cancer	2.39e-05	0.000162	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GGT1—liver cancer	2.39e-05	0.000162	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PIK3CA—liver cancer	2.38e-05	0.000161	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PPARA—liver cancer	2.36e-05	0.00016	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PIK3CA—liver cancer	2.35e-05	0.000159	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.32e-05	0.000157	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GLUL—liver cancer	2.3e-05	0.000156	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CPT1B—liver cancer	2.3e-05	0.000156	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—HPGDS—liver cancer	2.27e-05	0.000154	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—HPGDS—liver cancer	2.25e-05	0.000152	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.23e-05	0.000151	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—NR1H4—liver cancer	2.22e-05	0.00015	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTA3—liver cancer	2.18e-05	0.000148	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GSTP1—liver cancer	2.14e-05	0.000145	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—HMOX1—liver cancer	2.11e-05	0.000143	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.04e-05	0.000138	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PIK3CG—liver cancer	2.02e-05	0.000137	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PSMD10—liver cancer	2.02e-05	0.000137	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PSMA4—liver cancer	2.02e-05	0.000137	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.01e-05	0.000136	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PSMA4—liver cancer	2e-05	0.000136	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PSMD10—liver cancer	2e-05	0.000136	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTA4—liver cancer	1.99e-05	0.000135	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GSTM1—liver cancer	1.97e-05	0.000133	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GOT2—liver cancer	1.97e-05	0.000133	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PPARG—liver cancer	1.95e-05	0.000132	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GOT2—liver cancer	1.95e-05	0.000132	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—AKT1—liver cancer	1.95e-05	0.000132	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTA2—liver cancer	1.94e-05	0.000132	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—AKT1—liver cancer	1.92e-05	0.00013	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTA1—liver cancer	1.88e-05	0.000127	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CYP1A1—liver cancer	1.87e-05	0.000127	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—NAT2—liver cancer	1.85e-05	0.000126	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP2E1—liver cancer	1.85e-05	0.000125	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP2E1—liver cancer	1.83e-05	0.000124	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PIK3CD—liver cancer	1.78e-05	0.000121	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ALDOB—liver cancer	1.78e-05	0.00012	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.77e-05	0.00012	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ALB—liver cancer	1.76e-05	0.000119	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—MTHFR—liver cancer	1.74e-05	0.000118	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYCS—liver cancer	1.73e-05	0.000117	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYCS—liver cancer	1.71e-05	0.000116	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PPARA—liver cancer	1.71e-05	0.000116	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GOT1—liver cancer	1.7e-05	0.000115	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GGT1—liver cancer	1.7e-05	0.000115	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CRABP1—liver cancer	1.7e-05	0.000115	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GOT1—liver cancer	1.68e-05	0.000114	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GGT1—liver cancer	1.68e-05	0.000114	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PIK3CB—liver cancer	1.55e-05	0.000105	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GSTP1—liver cancer	1.52e-05	0.000103	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GSTP1—liver cancer	1.51e-05	0.000102	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—HMOX1—liver cancer	1.5e-05	0.000102	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—HMOX1—liver cancer	1.49e-05	0.000101	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—HPGDS—liver cancer	1.48e-05	0.0001	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PIK3CG—liver cancer	1.46e-05	9.91e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PPARG—liver cancer	1.41e-05	9.56e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GSTM1—liver cancer	1.4e-05	9.49e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GSTM1—liver cancer	1.39e-05	9.41e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP1A1—liver cancer	1.33e-05	9e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PSMD10—liver cancer	1.32e-05	8.95e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PSMA4—liver cancer	1.32e-05	8.95e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP1A1—liver cancer	1.32e-05	8.92e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PIK3CD—liver cancer	1.29e-05	8.71e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GOT2—liver cancer	1.29e-05	8.71e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ALB—liver cancer	1.27e-05	8.6e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—MTHFR—liver cancer	1.24e-05	8.39e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—MTHFR—liver cancer	1.23e-05	8.31e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PPARA—liver cancer	1.21e-05	8.23e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP2E1—liver cancer	1.21e-05	8.19e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PPARA—liver cancer	1.2e-05	8.16e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYCS—liver cancer	1.13e-05	7.66e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PIK3CB—liver cancer	1.12e-05	7.59e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GOT1—liver cancer	1.11e-05	7.52e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GGT1—liver cancer	1.11e-05	7.52e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.08e-05	7.33e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PIK3CG—liver cancer	1.04e-05	7.05e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PIK3CG—liver cancer	1.03e-05	6.98e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PPARG—liver cancer	1e-05	6.8e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTP1—liver cancer	9.97e-06	6.75e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PPARG—liver cancer	9.95e-06	6.74e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—HMOX1—liver cancer	9.83e-06	6.66e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PIK3CA—liver cancer	9.45e-06	6.4e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTM1—liver cancer	9.16e-06	6.2e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PIK3CD—liver cancer	9.14e-06	6.19e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PIK3CD—liver cancer	9.07e-06	6.14e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ALB—liver cancer	9.03e-06	6.11e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ALB—liver cancer	8.95e-06	6.06e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP1A1—liver cancer	8.68e-06	5.88e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—MTHFR—liver cancer	8.09e-06	5.48e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PIK3CB—liver cancer	7.97e-06	5.4e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PPARA—liver cancer	7.94e-06	5.38e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PIK3CB—liver cancer	7.9e-06	5.35e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—AKT1—liver cancer	7.72e-06	5.23e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PIK3CA—liver cancer	6.83e-06	4.63e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PIK3CG—liver cancer	6.8e-06	4.61e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PPARG—liver cancer	6.56e-06	4.45e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PIK3CD—liver cancer	5.98e-06	4.05e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ALB—liver cancer	5.9e-06	4e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—AKT1—liver cancer	5.58e-06	3.78e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PIK3CB—liver cancer	5.21e-06	3.53e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PIK3CA—liver cancer	4.86e-06	3.29e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PIK3CA—liver cancer	4.82e-06	3.26e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—AKT1—liver cancer	3.97e-06	2.69e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—AKT1—liver cancer	3.93e-06	2.67e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PIK3CA—liver cancer	3.18e-06	2.15e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—AKT1—liver cancer	2.6e-06	1.76e-05	CbGpPWpGaD
